Completed

HPV Knowledge in Homosexual Males

What is being tested

Safe and Protected Sex" intervention targeting HPV

+ Diptych of the Secretary of Health in Mexico

Behavioral

Who is being recruted

+5 Eligibility Criteria

See all eligibility criteria

How is the trial designed

Prevention Study

Placebo-Controlled

Interventional

Study Start: December 2021

See protocol details

Summary

Principal SponsorHospital Univeristario Benemerita Universidad Autonoma de Puebla

Last updated: January 28, 2026

Sourced from a government-validated database.Claim as a partner

Study start date: December 1, 2021

Actual date on which the first participant was enrolled.

This study focuses on improving the knowledge of Human Papillomavirus (HPV) among homosexual men, a group with a high prevalence of HPV infection. The study addresses key behavioral factors such as frequent sexual partnerships and inconsistent condom usage, which contribute to the spread of sexually transmitted infections (STIs) in this population. The "Safe and Protected Sex" program aims to educate participants about HPV, using an engaging and interactive method, to promote better sexual health practices and awareness. Participants in the study take part in an educational program designed to enhance their understanding of HPV. The study uses a test-retest approach, where knowledge levels are measured before and after the intervention to assess its effectiveness. Forty homosexual men are involved, divided into two groups of twenty. The goal is to determine if the program successfully increases awareness and understanding of HPV among the participants, potentially leading to more informed health choices and reduced STI rates.

Official TitleIntervention Toward Knowledge of Human Papillomavirus in Homosexual Males

NCT06920589

Principal SponsorHospital Univeristario Benemerita Universidad Autonoma de Puebla

Last updated: January 28, 2026

Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

40 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Prevention Study

Prevention studies aim to stop a disease from developing. They often involve people at risk and test things like vaccines, lifestyle changes, or preventive medications.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.

Criteria

Male

Biological sex of participants that are eligible to enroll.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Criteria

4 inclusion criteria required to participate

Males who self-identify as homosexual and/or bisexual.

Engage in sexual relationships with individuals of the same sex.

Willing to voluntarily participate in the study.

Have provided informed consent.

1 exclusion criteria prevent from participating

Homosexual and/or bisexual males with a profession related to the healthcare field.

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.

Treatment Groups

Study Objectives

2 intervention groups are designated in this study

50% chance of being blinded to the placebo group

Treatment Groups

Group I

Experimental

This study used the "Safe and Protected Sex" intervention, adapted and validated from an HIV prevention program to focus on HPV. The intervention consists of a single module with two stages aimed at increasing HPV knowledge by enhancing personal (self-determination) and social (controlled behavior) motivation. Module 1: "Nursing Consultation on HPV" This structured, planned process follows Corona and Kaltmeier's (2012) horizontal methodology, promoting self-care through social support and trust in nurse-patient dialogue. The goal is to provide counseling on HPV prevention and responsible sexual behavior while acknowledging participants' prior knowledge. Stage 1: 4.21-minute educational video, "HPV Fun Facts," uses persuasive narrative to explain HPV transmission, symptoms, complications, and prevention. Stage 2: 45-minute "Friendly Educational Guidance" session uses open-ended questions to explore participants' experiences, clarify misconceptions, and reinforce key information

Group II

Placebo

For the QA, the baseline measurement (test) was performed once the participant arrived at the sexual health clinic of the School of Nursing with the use of an electronic device that contained the first link of the QuestionPro® platform; subsequently, the participant was given information related to HPV through the usual methodology (diptych) (See Appendix H) that the health system in Mexico carries out. Finally, the second measurement was performed after reading the diptych with the use of the electronic device and the second link of the QuestionPro® platform, prior to the application of the intervention.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

School of Nursing Benemérita Universidad Autonoma de Puebla

Puebla City, MexicoOpen School of Nursing Benemérita Universidad Autonoma de Puebla in Google Maps

CompletedOne Study Center